Grifols SA (GRFS) stock
GRFSNasdaqPharmaceutical PreparationsAlso trades as GIFLF, GIFOF, GIKLY
$8.80−0.04 (-0.45%)
Close on Nov 12, 2026Market cap $3.03BP/E 6.7Yield –
Grifols EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was 0.59 EUR, up 156.5% from the year before. Over ten years it grew -2.8% a year on average. The highest annual figure on record is 0.97 EUR in fiscal 2017.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0.59 EUR | +156.5% |
| FY2024 | Dec 31, 2024 | 0.23 EUR | +283.3% |
| FY2023 | Dec 31, 2023 | 0.06 EUR | -77.8% |
| FY2022 | Dec 31, 2022 | 0.27 EUR | -3.6% |
| FY2021 | Dec 31, 2021 | 0.28 EUR | -68.9% |
| FY2020 | Dec 31, 2020 | 0.90 EUR | -1.1% |
| FY2019 | Dec 31, 2019 | 0.91 EUR | +4.6% |
| FY2018 | Dec 31, 2018 | 0.87 EUR | -10.3% |
| FY2017 | Dec 31, 2017 | 0.97 EUR | +21.2% |
| FY2016 | Dec 31, 2016 | 0.80 EUR | +2.6% |
| FY2015 | Dec 31, 2015 | 0.78 EUR | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?